Biotech Firm Celularity Faces Nasdaq Delisting Threat Amid Financial Restructuring
Celularity Inc. finds itself navigating a critical period as it confronts potential delisting from the Nasdaq exchange. The biotechnology company ...
© 2024 Stocks Today